TNDM NASDAQ
Tandem Diabetes Care, Inc.
1W: +5.0%
1M: -19.8%
3M: +7.0%
YTD: -23.4%
1Y: +33.0%
3Y: -20.7%
5Y: -86.7%
$16.50
+0.00 (+0.00%)
Weekly Expected Move ±8.7%
$14
$15
$16
$18
$19
Overview
News
Chart
Smart Money
Financials
Income Statement
Cash Flow
Balance Sheet
Earnings
Dividends
Analysis
Technicals
Weather
Peers
ESG
Institutions
ETF Exposure
Dark Pool
Short Interest
Supply Chain
Supply Chain Overview
10 relationships10
As Filer
counterparties named
0
As Counterparty
mentioned by others
2
Rel. Types
2022-12-13
Earliest Filing
2025-05-23
Latest Filing
partner: 8
target: 2
Counterparties (Filed by TNDM)
10 relationshipsCompanies named in TNDM's SEC 8-K filings as business counterparties.
| Counterparty | Ticker | Relationship | Summary | Filing Date | SEC |
|---|---|---|---|---|---|
| F. Hoffmann-La Roche AG | — | partner | Entered into a settlement and cross-license agreement to resolve patent disputes regarding insulin delivery systems. | 2025-05-23 | View |
| Roche Diabetes Care GmbH | — | partner | Part of the Roche Entities group involved in the patent dispute settlement and cross-licensing agreement. | 2025-05-23 | View |
| Roche Diabetes Care, Inc. | — | partner | Part of the Roche Entities group involved in the patent dispute settlement and cross-licensing agreement. | 2025-05-23 | View |
| Roche Diagnostics Operations Inc. | — | partner | Part of the Roche Entities group involved in the patent dispute settlement and cross-licensing agreement. | 2025-05-23 | View |
| Roche Diagnostics GmbH | — | partner | Part of the Roche Entities group involved in the patent dispute settlement and cross-licensing agreement. | 2025-05-23 | View |
| Roche Diagnostics International AG | — | partner | Part of the Roche Entities group involved in the patent dispute settlement and cross-licensing agreement. | 2025-05-23 | View |
| Dexcom, Inc. | DXCM | partner | Partnered with Tandem Diabetes Care, Inc. to integrate Sigi insulin pumps with G7 CGM devices under amended development | 2024-06-18 | View |
| Unomedical a/s | — | partner | Amendment to Distributor Agreement extending term and amending terms related to manufacturing and distributorship. | 2024-05-16 | View |
| AMF Medical | — | target | Target company acquired by Tandem Diabetes Care, Inc. | 2023-01-23 | View |
| AMF Medical SA | — | target | Target company acquired by Tandem Diabetes Care, Inc. in a share purchase agreement. | 2022-12-13 | View |
Recent 8-K Filings (20)
| Filing Date | Description | Type | SEC |
|---|---|---|---|
| 2026-05-21 | Officer/Director Change; Shareholder Vote; Exhibits | View | |
| 2026-05-15 | Officer/Director Change | View | |
| 2026-02-27 | Entry into Material Definitive Agreement; Creation of Direct Financial Obligation; Unregistered Sale | Agreement | View |
| 2026-02-19 | Results of Operations and Financial Condition; Financial Statements and Exhibits | View | |
| 2025-12-30 | Amendments to Articles of Incorporation or Bylaws; Financial Statements and Exhibits | View | |
| 2025-11-12 | Departure/Election of Directors; Appointment of Officers; Financial Statements and Exhibits | View | |
| 2025-11-06 | Results of Operations and Financial Condition; Financial Statements and Exhibits | View | |
| 2025-08-07 | Other Events | View | |
| 2025-08-06 | Results of Operations and Financial Condition; Financial Statements and Exhibits | View | |
| 2025-05-23 | Entry into Material Definitive Agreement; Submission of Matters to a Vote of Security Holders | Agreement | View |
| 2025-05-20 | Other Events | View | |
| 2025-05-12 | Other Events | View | |
| 2025-04-30 | Results of Operations and Financial Condition; Financial Statements and Exhibits | View | |
| 2025-02-26 | Results of Operations and Financial Condition; Financial Statements and Exhibits | View | |
| 2024-11-06 | Results of Operations and Financial Condition; Financial Statements and Exhibits | View | |
| 2024-08-01 | Results of Operations and Financial Condition; Financial Statements and Exhibits | View | |
| 2024-06-21 | Departure/Election of Directors; Appointment of Officers | View | |
| 2024-06-18 | Entry into Material Definitive Agreement | Agreement | View |
| 2024-05-23 | Departure/Election of Directors; Appointment of Officers; Submission of Matters to a Vote of Securit | View | |
| 2024-05-16 | Entry into Material Definitive Agreement; Other Events; Financial Statements and Exhibits | Agreement | View |
Data extracted from SEC EDGAR 8-K filings using NLP. Relationships are as disclosed in filing text.
Covers 2021–2026. View on SEC EDGAR